Foundayo™

*Rx subject to provider review & clinical eligibility. See site for black box warnings & risk info. Pricing reflects insurance coverage for clinical care & multi-mo. commitment; see offer terms. Copays, coinsurance, deductibles may apply. Found is not affiliated w/ or endorsed by Eli Lilly (Foundayo TM). In studies of orforglipron (Foundayo), patients on the highest dose lost an average of ~11% of their body weight (~25 lbs) at 72 weeks, when used with diet and exercise. Individual results may vary.

Foundayo™ Online Prescription for Weight Loss

GLP-1,oral-tablet,orforglipron

Foundayo mimics glucagon-like peptide-1 (GLP-1), a gut hormone released when you eat that slows digestion and helps you feel full. Unlike GLP-1 injections, Foundayo is a once-daily pill you can take any time of day — with or without food. It can help adults with obesity or overweight lose an average of 11% of their body weight when used alongside diet and exercise.* Foundayo also:

Regulates insulin

Balances blood sugar

Reduces appetite

Get started

Learn more

Everything you need to know about
Foundayo™

Basics

Benefits How it works How to use it

What
is
are
Foundayo™
?

Foundayo is a drug approved by the U.S. Food and Drug Administration (FDA) on April 1, 2026, for chronic weight management. It is prescribed for adults with obesity, or who are overweight (a BMI of 27 or higher) with at least one weight-related health condition such as high blood pressure, heart disease, or kidney disease.

Foundayo is a brand name for orforglipron, a small molecule GLP-1 receptor agonist manufactured by Eli Lilly. Unlike Lilly's other weight loss medication, Zepbound, Foundayo is not a peptide — it's a small molecule drug, which means it's absorbed differently by the body and can be taken at any time of day without food or water restrictions.

Foundayo is available as an oral tablet in six doses: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg. It is the second GLP-1 pill approved by the FDA for obesity, following the approval of Novo Nordisk's Wegovy pill in December 2025. It was approved in just 50 days — the fastest approval of a new molecular entity since 2002 — under the FDA's Commissioner's National Priority Voucher program.

GLP-1 weight loss medication comparison

	Foundayo™	Wegovy® Pill	Wegovy® Pen	Zepbound®
Active ingredient	Orforglipron	Semaglutide	Semaglutide	Tirzepatide
Drug class	GLP-1	GLP-1	GLP-1	GLP-1 / GIP
Form	Oral tablet	Oral tablet	Injection	Injection
Dosing frequency	Once daily	Once daily	Once weekly	Once weekly
Avg. weight loss‡	~11%	~14%	~15%	~21%
Food restrictions	None	Empty stomach + 30 min wait	None	None
Refrigeration required	No	No	Yes	Yes
FDA approved for weight loss	Yes	Yes	Yes	Yes
Manufacturer	Eli Lilly	Novo Nordisk	Novo Nordisk	Eli Lilly
Starting cash price	~$149/mo	~$149/mo	~$199/mo	~$299/mo

‡ Average weight loss with diet and exercise in Phase 3 clinical trials at highest approved dose, regardless of treatment adherence. Individual results will vary. All prescriptions are at the discretion of a medical provider.

Benefits of
Foundayo™

Expected weight loss depends on the dosage and how long you take the medication.

In the ATTAIN-1 clinical trial, adults taking the highest dose of Foundayo lost an average of 11% of their body weight — about 25 pounds — over 72 weeks, with diet and exercise, compared to participants taking a placebo who lost an average of about 2% over the same period.‡

Foundayo may also support cardiovascular health by helping improve blood pressure, blood sugar, and cholesterol levels in those who lose weight. Lilly is continuing to study Foundayo's effects on cardiovascular outcomes.

Some patients in clinical trials reported reduced cravings and food noise, as well as improvements in energy, sleep, and overall quality of life.

*Average weight loss with diet and exercise in the ATTAIN-1 Phase 3 clinical trial (72 weeks, highest approved dose), regardless of treatment adherence. Individual results will vary. All prescriptions are at the discretion of a medical provider.

How
does
do
Foundayo™
work?

When you eat, your gut releases GLP-1, a hormone that helps the pancreas release the right amount of insulin, slows the movement of food through the digestive system, and signals fullness to the brain.

In some people, the body doesn't produce enough GLP-1, or the brain doesn't respond to it as strongly. Foundayo is a synthetic GLP-1 receptor agonist — a drug that activates the same cell receptors as your body's natural GLP-1 hormone, helping trigger the same responses: slowing digestion, reducing hunger, and regulating blood sugar after meals.

What sets Foundayo apart from other GLP-1 medications is its chemical structure. Foundayo is a small molecule, not a peptide. This means it's absorbed directly through the gut without needing special handling — so unlike the Wegovy pill, there are no food, water, or timing restrictions.

Because Foundayo supports a process the body may not be doing well on its own, it may require long-term use.

Foundayo doesn't work for everyone. Found's clinicians, trained in obesity medicine, can help identify the root cause of your weight gain and personalize a treatment plan to target it. All prescriptions are at the discretion of a medical provider.

How to use it

Foundayo is taken once daily. It can be taken at any time of day, with or without food or water restrictions. Swallow tablets whole — do not break, crush, or chew. Follow your care provider's instructions for use.

Dosing

Foundayo is available in six doses: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg. Patients typically start at 0.8 mg, increasing to 2.5 mg after at least 30 days, then to 5.5 mg after another 30 days. The dosage may be increased further to 9 mg, 14.5 mg, or 17.2 mg after at least 30 days at each level, based on treatment response and tolerability. Your care provider will determine the right dose and schedule. Please also read the pharmaceutical packaging.

Side effects

Commonly reported side effects of this medication include:

Nausea
Constipation
Diarrhea
Vomiting
Indigestion
Stomach (abdominal) pain
Headache

Other potential side effects:

Swollen belly (abdominal distension)
Fatigue
Belching
Heartburn
Gas
Hair loss
Decreased appetite
Gastroesophageal reflux disease
Altered taste

These symptoms often subside as your body adjusts to the medication. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.

Black Box Warning

Although rare, GLP-1 receptor agonists including Foundayo may cause thyroid C-cell tumors. Foundayo carries a "black box" warning for this risk. If you experience a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath, contact your healthcare provider immediately.

Do not take Foundayo if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome Type 2 (MEN 2).

‍

Precautions

Rapid weight loss can lead to muscle loss. To protect your muscle mass, it's important to incorporate strength training and regular exercise while taking Foundayo.

If you take oral birth control pills, talk to your healthcare provider before starting Foundayo. Birth control pills may be less effective while taking Foundayo — your provider may recommend an alternative form of contraception for 30 days after starting Foundayo and for 30 days after each dose increase.

If you are pregnant, planning to become pregnant, or breastfeeding, do not take Foundayo. Foundayo may cause fetal harm and should be discontinued when pregnancy is confirmed.

If you are going under general anesthesia or deep sedation, inform your provider that you are taking Foundayo, as it may slow gastric emptying and increase the risk of pulmonary aspiration.

Interactions

Some drugs can interact with Foundayo, including:

Insulin and sulfonylureas, which can cause blood sugar levels to drop too low
Oral birth control pills
Other GLP-1 receptor agonist medications — use of Foundayo with other GLP-1 medications is not recommended

Avoid alcohol while taking this drug, as it can lower blood sugar and may cause dizziness or fainting when combined with Foundayo.

about
found

Found is an online weight loss program offering personalized care for every member. Some of the nation’s top obesity medicine specialists helped design our program. Our approach is based on science, and we’re committed to clinical excellence.

Members get access to: Clinicians trained in obesity medicine, self-paced lifestyle change program designed by doctors, psychologists, and behavioral scientists & our exclusive in-app community.

Found’s comprehensive program is designed to work with your body—so you can achieve lasting results and enjoy better health.

_{Found is not affiliated or endorsed by Novo Nordisk A/S., the owner of the registered trademarks Wegovy®, Ozempic®, Saxenda®, and Victoza®, nor is it affiliated or endorsed by Eli Lilly & Co., the owner of the registered trademarks Zepbound®, Mounjaro®, and Foundayo™. Certain GLP-1 medications are only FDA approved to treat conditions other than weight but may be prescribed to help aid in weight loss. Rx are up to a medical provider’s discretion and not available in all states.}

Alternative medications

Depending on your health history, weight history, and MetabolicPrint^TM assessment, your Found health care provider may consider other alternatives to help you lose weight. Some are FDA-approved for weight loss. Others are used off-label and have strong clinical evidence supporting their use for weight loss.

Unfortunately, there are no generic versions of Ozempic currently on the market.
However, your health care provider might consider alternatives such as Wegovy, Mounjaro, or Saxenda, all of which are GLP-1 medications but not all are FDA-approved for weight loss specifically.

Foundayo™ Online Prescription for Weight Loss